ID

41817

Beskrivning

Nitroglycerin in Non-small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01210378

Länk

https://clinicaltrials.gov/show/NCT01210378

Nyckelord

Versioner (3)
  1. 2021-01-21 2021-01-21 - Ahmed Rafee, MD
  2. 2021-01-21 2021-01-21 - Ahmed Rafee, MD
  3. 2021-01-22 2021-01-22 - Sarah Riepenhausen
Rättsinnehavare

Maastricht Radiation Oncology

Uppladdad den

22 januari 2021

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Non Small Cell Lung Cancer (NSCLC) NCT01210378

Engelsk

Eligibility Non Small Cell Lung Cancer (NSCLC) NCT01210378

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
non-small cell lung cancer stage ib-iv amenable for radiotherapy with curative intent.
Beskrivning

non-small cell lung cancer stage ib-iv amenable for radiotherapy with curative intent.

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C1300072
UMLS CUI [1,3]
C3900053
UMLS CUI [1,4]
C1522449
UMLS CUI [1,5]
C1276305
(stage iv patients with oligometastic (1-4 metastases) nsclc are regularly treated radically in the iknl region).
Beskrivning

(stage iv patients with oligometastic (1-4 metastases) nsclc are regularly treated radically in the iknl region).

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C1300072
UMLS CUI [1,3]
C0439807
UMLS CUI [1,4]
C0449788
UMLS CUI [1,5]
C0027627
patients not included in the pet-boost or the lucanix trial.
Beskrivning

patients not included in the pet-boost or the lucanix trial.

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0332197
who performance status 0-2.
Beskrivning

who performance status 0-2.

Datatyp

boolean

Alias
UMLS CUI [1]
C1298650
willing and able to comply with the study prescriptions.
Beskrivning

willing and able to comply with the study prescriptions.

Datatyp

boolean

Alias
UMLS CUI [1]
C0525058
18 years or older.
Beskrivning

18 years or older.

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
ability to give and having given written informed consent before patient registration.
Beskrivning

ability to give and having given written informed consent before patient registration.

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0085732
UMLS CUI [2]
C0021430
no recent (< 3 months) severe cardiac disease (nyha class >1) (congestive heart failure, infarction).
Beskrivning

no recent (< 3 months) severe cardiac disease (nyha class >1) (congestive heart failure, infarction).

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0332197
UMLS CUI [1,4]
C0332185
UMLS CUI [2]
C1275491
UMLS CUI [3,1]
C0018802
UMLS CUI [3,2]
C0205082
UMLS CUI [3,3]
C0332197
UMLS CUI [3,4]
C0332185
UMLS CUI [4,1]
C0027051
UMLS CUI [4,2]
C0205082
UMLS CUI [4,3]
C0332197
UMLS CUI [4,4]
C0332185
no radiotherapy in 4 weeks prior to this study.
Beskrivning

no radiotherapy in 4 weeks prior to this study.

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0332185
UMLS CUI [1,3]
C0332197
no treatment with investigational drugs in 4 weeks prior to or during this study.
Beskrivning

no treatment with investigational drugs in 4 weeks prior to or during this study.

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0332185
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0008976
no known allergy to nitroglycerin or nitroglycerin patch.
Beskrivning

no known allergy to nitroglycerin or nitroglycerin patch.

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0017887
UMLS CUI [1,2]
C0020517
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0017887
UMLS CUI [2,2]
C0991556
UMLS CUI [2,3]
C0020517
UMLS CUI [2,4]
C0332197
no known allergy to iodine based contrast agents
Beskrivning

no known allergy to iodine based contrast agents

Datatyp

boolean

Alias
UMLS CUI [1,1]
C4022917
UMLS CUI [1,2]
C0332197
no use of levitra, viagra or cialis at the time of application of the nitroglycerin patch.
Beskrivning

no use of levitra, viagra or cialis at the time of application of the nitroglycerin patch.

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1317775
UMLS CUI [1,2]
C0017887
UMLS CUI [1,3]
C0991556
UMLS CUI [1,4]
C0663448
UMLS CUI [1,5]
C0332197
UMLS CUI [2,1]
C1317775
UMLS CUI [2,2]
C0017887
UMLS CUI [2,3]
C0991556
UMLS CUI [2,4]
C1174890
UMLS CUI [2,5]
C0332197
UMLS CUI [3,1]
C1317775
UMLS CUI [3,2]
C0017887
UMLS CUI [3,3]
C0991556
UMLS CUI [3,4]
C0967376
UMLS CUI [3,5]
C0332197
no conditions necessitating the use of ergot alkaloids, alpha blockers (eg tamsulosine), betablockers or calcium channel blockers on the day of nitroglycerin patch application).
Beskrivning

no conditions necessitating the use of ergot alkaloids, alpha blockers (eg tamsulosine), betablockers or calcium channel blockers on the day of nitroglycerin patch application).

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0014707
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0001641
UMLS CUI [2,2]
C3146298
UMLS CUI [2,3]
C0332197
UMLS CUI [3,1]
C0304516
UMLS CUI [3,2]
C3146298
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C0006684
UMLS CUI [4,2]
C3146298
UMLS CUI [4,3]
C0332197
no other active malignancy.
Beskrivning

no other active malignancy.

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0332197
no major surgery (excluding diagnostic procedures like eg mediastinoscopy) in previous 4 weeks.
Beskrivning

no major surgery (excluding diagnostic procedures like eg mediastinoscopy) in previous 4 weeks.

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0679637
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0332185
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0025065
adequate renal function: calculated creatinine clearance at least 60ml/min.
Beskrivning

adequate renal function: calculated creatinine clearance at least 60ml/min.

Datatyp

boolean

Alias
UMLS CUI [1]
C0373595
Tillbaka till toppen

Similar models

Eligibility Non Small Cell Lung Cancer (NSCLC) NCT01210378

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
non-small cell lung cancer stage ib-iv amenable for radiotherapy with curative intent.
Item
non-small cell lung cancer stage ib-iv amenable for radiotherapy with curative intent.
boolean
C0007131 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
C3900053 (UMLS CUI [1,3])
C1522449 (UMLS CUI [1,4])
C1276305 (UMLS CUI [1,5])
(stage iv patients with oligometastic (1-4 metastases) nsclc are regularly treated radically in the iknl region).
Item
(stage iv patients with oligometastic (1-4 metastases) nsclc are regularly treated radically in the iknl region).
boolean
C0007131 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
C0439807 (UMLS CUI [1,3])
C0449788 (UMLS CUI [1,4])
C0027627 (UMLS CUI [1,5])
patients not included in the pet-boost or the lucanix trial.
Item
patients not included in the pet-boost or the lucanix trial.
boolean
C2348568 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
who performance status 0-2.
Item
who performance status 0-2.
boolean
C1298650 (UMLS CUI [1])
willing and able to comply with the study prescriptions.
Item
willing and able to comply with the study prescriptions.
boolean
C0525058 (UMLS CUI [1])
18 years or older.
Item
18 years or older.
boolean
C0001779 (UMLS CUI [1])
ability to give and having given written informed consent before patient registration.
Item
ability to give and having given written informed consent before patient registration.
boolean
C0021430 (UMLS CUI [1,1])
C0085732 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
no recent (< 3 months) severe cardiac disease (nyha class >1) (congestive heart failure, infarction).
Item
no recent (< 3 months) severe cardiac disease (nyha class >1) (congestive heart failure, infarction).
boolean
C0018799 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0332185 (UMLS CUI [1,4])
C1275491 (UMLS CUI [2])
C0018802 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C0332185 (UMLS CUI [3,4])
C0027051 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
C0332185 (UMLS CUI [4,4])
no radiotherapy in 4 weeks prior to this study.
Item
no radiotherapy in 4 weeks prior to this study.
boolean
C1522449 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
no treatment with investigational drugs in 4 weeks prior to or during this study.
Item
no treatment with investigational drugs in 4 weeks prior to or during this study.
boolean
C0013230 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0013230 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
no known allergy to nitroglycerin or nitroglycerin patch.
Item
no known allergy to nitroglycerin or nitroglycerin patch.
boolean
C0017887 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0017887 (UMLS CUI [2,1])
C0991556 (UMLS CUI [2,2])
C0020517 (UMLS CUI [2,3])
C0332197 (UMLS CUI [2,4])
no known allergy to iodine based contrast agents
Item
no known allergy to iodine based contrast agents
boolean
C4022917 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
no use of levitra, viagra or cialis at the time of application of the nitroglycerin patch.
Item
no use of levitra, viagra or cialis at the time of application of the nitroglycerin patch.
boolean
C1317775 (UMLS CUI [1,1])
C0017887 (UMLS CUI [1,2])
C0991556 (UMLS CUI [1,3])
C0663448 (UMLS CUI [1,4])
C0332197 (UMLS CUI [1,5])
C1317775 (UMLS CUI [2,1])
C0017887 (UMLS CUI [2,2])
C0991556 (UMLS CUI [2,3])
C1174890 (UMLS CUI [2,4])
C0332197 (UMLS CUI [2,5])
C1317775 (UMLS CUI [3,1])
C0017887 (UMLS CUI [3,2])
C0991556 (UMLS CUI [3,3])
C0967376 (UMLS CUI [3,4])
C0332197 (UMLS CUI [3,5])
no conditions necessitating the use of ergot alkaloids, alpha blockers (eg tamsulosine), betablockers or calcium channel blockers on the day of nitroglycerin patch application).
Item
no conditions necessitating the use of ergot alkaloids, alpha blockers (eg tamsulosine), betablockers or calcium channel blockers on the day of nitroglycerin patch application).
boolean
C0014707 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0001641 (UMLS CUI [2,1])
C3146298 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0304516 (UMLS CUI [3,1])
C3146298 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C0006684 (UMLS CUI [4,1])
C3146298 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
no other active malignancy.
Item
no other active malignancy.
boolean
C0006826 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
no major surgery (excluding diagnostic procedures like eg mediastinoscopy) in previous 4 weeks.
Item
no major surgery (excluding diagnostic procedures like eg mediastinoscopy) in previous 4 weeks.
boolean
C0679637 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0025065 (UMLS CUI [2,2])
adequate renal function: calculated creatinine clearance at least 60ml/min.
Item
adequate renal function: calculated creatinine clearance at least 60ml/min.
boolean
C0373595 (UMLS CUI [1])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial